
|Articles|March 25, 2022
News Roundup: March 21 to March 25
Author(s)Lauren Biscaldi, MS
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
APhA “Perennial Favorite” New Drug Review Covers 15 FDA Approvals
The drugs treat a range of conditions, including migraine, Alzhiemer disease, and actinic keratosis.
The Future of Pharmacy is Digital
Patients need digital pharmacists to monitor the growing armamentarium of digital therapeutics and the flood of patient-specific data.
US Drug Prices Distorted to Favor Pharmacy Benefit Managers
PBMs use hidden rebates and other strategies to rig drug pricing and sidestep regulatory efforts
APhA: Annual Pediatric, Adult Immunization Update
There’s more to vaccines than just COVID-19.
OTC Update Reviews New Products, Recalls Since 2020
Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: Community Pharmacists Educate Patients on Safe Insulin Use
2
Scripted for Her: HRT Black Box Removal
3
Trial Approvals Face Delays During COVID-19 Pandemic
4
Trump Executive Order Set to Reclassify Marijuana, Improve CBD Access
5
















































































































